Bette Korber
The HIV-1 mosaic vaccine in the trial was originally designed at Los Alamos National Laboratory by theoretical biologist Bette Korber and her team. My life's work has been devoted to developing strategies to create a global HIV vaccine; mosaics were a realization of one such strategy. Bette Korber Novel viral analysis approach leads to potential 'global vaccine'. LOS ALAMOS, N.M. Nov. 30, 2017-Just in time for World AIDS Day (Dec. 1) international partners are announcing the first efficacy study for an investigational HIV-1-preventive "mosaic” vaccine. Janssen Pharmaceutical Companies of Johnson & Johnson are joining forces with The Bill & Melinda Gates Foundation and National Institutes of Health on this study, and they have enlisted the aid of top researchers worldwide to conduct the trial.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
